{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:19:37Z","timestamp":1792084777164,"version":"4.4.0"},"reference-count":260,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2000,5,1]]},"DOI":"10.1038\/sj.mp.4000697","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T18:52:02Z","timestamp":1031165522000},"page":"242-261","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":86,"title":["Dysthymia: a review of pharmacological and behavioral factors"],"prefix":"10.1038","volume":"5","author":[{"given":"J","family":"Griffiths","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A V","family":"Ravindran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Merali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Anisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2000,6,28]]},"reference":[{"key":"BF4000697_CR1","first-page":"478","volume":"1","author":"HS Akiskal","year":"1996","unstructured":"Akiskal HS, Bolis CL, Cazzullo C, Costa e Silva JA, Gentil V, Lecrubier Y et al. Dysthymia in neurological disorders Mol Psychiatry 1996; 1: 478\u2013491","journal-title":"Mol Psychiatry"},{"key":"BF4000697_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0006-3223(91)90112-Y","volume":"30","author":"RH Howland","year":"1991","unstructured":"Howland RH, Thase ME . Biological studies of dysthymia Biol Psychiatry 1991; 30: 283\u2013304","journal-title":"Biol Psychiatry"},{"key":"BF4000697_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0193-953X(05)70272-0","volume":"19","author":"DN Klein","year":"1996","unstructured":"Klein DN, Kocsis JH, McCullough JP, Holzer CE, Hirschfeld RM, Keller MB . Symptomatology in dysthymic and major depressive disorder Psychiat Clin North Am 1996; 19: 41\u201353","journal-title":"Psychiat Clin North Am"},{"key":"BF4000697_CR4","first-page":"21","volume-title":"Dysthymia: From Clinical Neuroscience to Treatment","author":"AV Ravindran","year":"1997","unstructured":"Ravindran AV, Merali Z, Anisman H . Dysthymia: a biological perspective. In: Licinio J, Bolis CL, Gold P (eds) Dysthymia: From Clinical Neuroscience to Treatment World Health Organization: Geneva 1997; pp21\u201344"},{"key":"BF4000697_CR5","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"Association American Psychiatric","year":"1994","unstructured":"American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders Editions 3 and 4; 1980 1994"},{"key":"BF4000697_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1176\/ajp.140.1.11","volume":"140","author":"HS Akiskal","year":"1983","unstructured":"Akiskal HS . Dysthymic disorder: psychopathology of proposed chronic depressive subtypes Am J Psychiatry 1983; 140: 11\u201320","journal-title":"Am J Psychiatry"},{"key":"BF4000697_CR7","first-page":"1","volume-title":"Dysthymia: From Clinical Neuroscience to Treatment","author":"H Freeman","year":"1997","unstructured":"Freeman H . How the concept of dysthymia has developed.: a biological perspective. In: Licinio J, Bolis CL, Gold P (eds) Dysthymia: From Clinical Neuroscience to Treatment World Health Organization: Geneva 1997; pp1\u20138"},{"key":"BF4000697_CR8","volume-title":"The ICD\u201310 classification of mental and behavioural disorders\u2014clinical descriptions and diagnostic guidelines","author":"Organization World Health","year":"1992","unstructured":"World Health Organization . The ICD\u201310 classification of mental and behavioural disorders\u2014clinical descriptions and diagnostic guidelines WHO: Geneva 1992"},{"key":"BF4000697_CR9","first-page":"1","volume-title":"Dysthymic Disorders","author":"HS Akiskal","year":"1990","unstructured":"Akiskal HS . Towards a definition of dysthymia: boundaries with personality and mood disorders. In: Burton SW, Akiskal HS (eds) Dysthymic Disorders Gaskell: London 1990; pp1\u201312"},{"key":"BF4000697_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0193-953X(05)70273-2","volume":"19","author":"JP McCullough","year":"1996","unstructured":"McCullough JP, Kornstein SG, McCullough JP, Belyea-Caldwell S, Kaye AL, Roberts C et al. Differential diagnosis of chronic depressive disorders Psychiatr Clin North Am 1996; 19: 41\u201353","journal-title":"Psychiatr Clin North Am"},{"key":"BF4000697_CR11","first-page":"13","volume-title":"Dysthymic Disorders","author":"MB Keller","year":"1990","unstructured":"Keller MB, Sessa FM . Dysthymia: development and clinical course. In: Burton SW, Akiskal HS (eds) Dysthymic Disorders Gaskell: London 1990; pp13\u201323"},{"key":"BF4000697_CR12","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1001\/archpsyc.1993.01820140007001","volume":"50","author":"DA Regier","year":"1993","unstructured":"Regier DA, Narrow WE, Rae DS, Manderscheid RW, Locke BZ, Goodwin FK . The de facto US mental and addictive disorders service system: Epidemiologic Catchment Area prospective 1-year prevalence rates of disorders and services Arch Gen Psychiatry 1993; 50: 85\u201394","journal-title":"Arch Gen Psychiatry"},{"key":"BF4000697_CR13","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1001\/archpsyc.1988.01800350011002","volume":"45","author":"DA Regier","year":"1988","unstructured":"Regier DA, Boyd JH, Burke JD, Rae DS, Myers JK, Kramer M et al. One-month prevalence of mental disorders in the United States Arch Gen Psychiatry 1988; 45: 977\u2013986","journal-title":"Arch Gen Psychiatry"},{"key":"BF4000697_CR14","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1176\/ajp.152.6.843","volume":"152","author":"MB Keller","year":"1995","unstructured":"Keller MB, Klein DN, Hirschfeld RMA, Docsis JH, McCullough JP, Miller I et al. Results of the DSM-IV Mood Disorders Field Trial Am J Psychiatry 1995; 152: 843\u2013849","journal-title":"Am J Psychiatry"},{"key":"BF4000697_CR15","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1001\/archpsyc.1984.01790140019002","volume":"41","author":"M Kovacs","year":"1984","unstructured":"Kovacs M, Feinberg TL, Crouse-Novak MA, Paulauskas SL, Finkelstein R . Depressive disorders in childhood, I: a longitudinal prospective study of characteristics and recovery Arch Gen Psychiatry 1984; 41: 229\u2013237","journal-title":"Arch Gen Psychiatry"},{"key":"BF4000697_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.4088\/JCP.v58n0202","volume":"58","author":"RC Shelton","year":"1997","unstructured":"Shelton RC, Davidson J, Yonkers KA, Koran L, Thase ME, Pearlstein T et al. The undertreatment of dysthymia J Clin Psychiatry 1997; 58: 59\u201365","journal-title":"J Clin Psychiatry"},{"key":"BF4000697_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/00004714-199104000-00003","volume":"11","author":"RH Howland","year":"1991","unstructured":"Howland RH . Pharmacotherapy of dysthymia: a review J Clin Psychopharmacol 1991; 11: 83\u201392","journal-title":"J Clin Psychopharmacol"},{"key":"BF4000697_CR18","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0165-0327(98)00228-6","volume":"51","author":"M Versiani","year":"1998","unstructured":"Versiani M . Pharmacotherapy of dysthymic and chronic depressive disorders: overview with focus on moclobemide J Affect Disord 1998; 51: 323\u2013332","journal-title":"J Affect Disord"},{"key":"BF4000697_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1176\/appi.psychotherapy.1992.46.1.9","volume":"46","author":"HS Akiskal","year":"1992","unstructured":"Akiskal HS, Weise RE . The clinical spectrum of so-called \u2018minor\u2019 depressions Am J Psychother 1992; 46: 9\u201322","journal-title":"Am J Psychother"},{"key":"BF4000697_CR20","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1176\/ajp.151.8.1114","volume":"151","author":"JC Markowitz","year":"1994","unstructured":"Markowitz JC . Psychotherapy of dysthymia Am J Psychiatry 1994; 151: 1114\u20131121","journal-title":"Am J Psychiatry"},{"key":"BF4000697_CR21","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1097\/00005053-199112000-00004","volume":"179","author":"JP McCullogh","year":"1991","unstructured":"McCullogh JP . Psychotherapy for dysthymia: a naturalistic study of ten patients J Nerv Ment Dis 1991; 179: 734\u2013740","journal-title":"J Nerv Ment Dis"},{"key":"BF4000697_CR22","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1176\/ajp.156.10.1608","volume":"156","author":"AV Ravindran","year":"1999","unstructured":"Ravindran AV, Anisman H, Merali Z, Charbonneau Y, Telner J, Bialik RJ et al. Treatment of primary dysthymia with group cognitive therapy and pharmacotherapy: clinical symptoms and functional impairments Am J Psychiatry 1999; 156: 1608\u20131617","journal-title":"Am J Psychiatry"},{"key":"BF4000697_CR23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/(SICI)1522-7162(1996)4:1<34::AID-DEPR4>3.0.CO;2-F","volume":"4","author":"DL Dunner","year":"1996","unstructured":"Dunner DL, Schmaling KB, Hendrickson H, Becker J, Lehman A, Bea C . Cognitive therapy versus fluoxetine in the treatment of dysthymic disorder Depression 1996; 4: 34\u201341","journal-title":"Depression"},{"key":"BF4000697_CR24","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1176\/ajp.139.4.438","volume":"139","author":"MB Keller","year":"1982","unstructured":"Keller MB, Shapiro RW . Double depression: superimposition of acute depressive episodes on chronic depressive disorders Am J Psychiatry 1982; 139: 438\u2013442","journal-title":"Am J Psychiatry"},{"key":"BF4000697_CR25","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1176\/ajp.140.6.689","volume":"140","author":"MB Keller","year":"1983","unstructured":"Keller MB, Lavori PW, Endicott J, Coryell W, Klerman GL . Double depression: two year follow up Am J Psychiatry 1983; 140: 689\u2013694","journal-title":"Am J Psychiatry"},{"key":"BF4000697_CR26","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1176\/ajp.145.7.815","volume":"145","author":"MM Weissman","year":"1988","unstructured":"Weissman MM, Leaf PJ, Bruce ML, Florio L . The epidemiology of dysthymia in five communities: rates, risks, comorbidity and treatment Am J Psychiatry 1988; 145: 815\u2013819","journal-title":"Am J Psychiatry"},{"key":"BF4000697_CR27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0165-0327(97)00085-2","volume":"47","author":"AJ Levitt","year":"1998","unstructured":"Levitt AJ, Joffe RT, Sokolov STH . Does the chronological relationship between the onset of dysthymia and major depression influence subsequent response to antidepressants? J Affect Disord 1998; 47: 169\u2013175","journal-title":"J Affect Disord"},{"key":"BF4000697_CR28","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0165-0327(96)01405-X","volume":"42","author":"S Pini","year":"1997","unstructured":"Pini S, Cassano GB, Simonini E, Savino M, Russo A, Montgomery SA . Prevalence of anxiety disorders comorbidity in bipolar depression, unipolar depression and dysthymia J Affect Disord 1997; 42: 145\u2013153","journal-title":"J Affect Disord"},{"key":"BF4000697_CR29","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1176\/ajp.145.3.293","volume":"145","author":"W Coryell","year":"1988","unstructured":"Coryell W, Endicott J, Andreasen N, Keller MB, Clayton PJ, Hirschfeld RM et al. Depression and panic attacks: the significance of overlap as reflected in follow-up and family study data Am J Psychiatry 1988; 145: 293\u2013300","journal-title":"Am J Psychiatry"},{"key":"BF4000697_CR30","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S0163-8343(99)00005-5","volume":"21","author":"BN Gaynes","year":"1999","unstructured":"Gaynes BN, Magruder KM, Burns BJ, Wagner R, Yarnall KSH, Broadhead WE . Does a coexisting anxiety disorder predict persistence of depressive illness in primary care patients with major depression? Gen Hosp Psychiatry 1999; 21: 158\u2013167","journal-title":"Gen Hosp Psychiatry"},{"key":"BF4000697_CR31","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1176\/ajp.152.2.239","volume":"152","author":"CM Pepper","year":"1995","unstructured":"Pepper CM, Klein DN, Anderson RL, Riso LP, Ouimette P, Lizardi H . DSM-III-R axis II comorbidity in dysthymia and major depression Am J Psychiatry 1995; 152: 239\u2013247","journal-title":"Am J Psychiatry"},{"key":"BF4000697_CR32","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0165-0327(92)90020-7","volume":"24","author":"JC Markowitz","year":"1992","unstructured":"Markowitz JC, Moran MM, Kocsis JH, Frances AJ . Prevalence and comorbidity of dysthymic disorder among psychiatric outpatients J Affect Disord 1992; 24: 63\u201367","journal-title":"J Affect Disord"},{"key":"BF4000697_CR33","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1521\/pedi.1993.7.3.223","volume":"7","author":"DB Marin","year":"1993","unstructured":"Marin DB, Kocsis JH, Frances AJ, Klerman GL . Personality disorders in dysthymia J Personality Disord 1993; 7: 223\u2013231","journal-title":"J Personality Disord"},{"key":"BF4000697_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0165-0327(95)00088-7","volume":"38","author":"RL Anderson","year":"1996","unstructured":"Anderson RL, Klein DN, Riso LP, Ouimette PC, Lizardi H, Schwartz JE . The subaffective-character spectrum subtyping distinction primary early-onset dysthymia: a clinical and familial study J Affect Disord 1996; 38: 13\u201322","journal-title":"J Affect Disord"},{"key":"BF4000697_CR35","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/j.1600-0447.1999.tb07238.x","volume":"99","author":"G Garyfallos","year":"1999","unstructured":"Garyfallos G, Adamopoulou A, Karastergiou A, Voikli M, Sotiropoulou A, Donias S et al. Personality disorders in dysthymia and major depression Acta Psychiat Scand 1999; 99: 332\u2013340","journal-title":"Acta Psychiat Scand"},{"key":"BF4000697_CR36","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0165-0327(98)00079-2","volume":"52","author":"DN Klein","year":"1999","unstructured":"Klein DN, Schatzberg AF, McCullough JP, Keller MB, Dowling F, Goodman D et al. Early- versus late-onset dysthymic disorder: comparison in out-patients with superimposed major depressive episodes J Affect Disord 1999; 52: 187\u2013196","journal-title":"J Affect Disord"},{"key":"BF4000697_CR37","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1037\/0021-843X.107.2.319","volume":"107","author":"DN Klein","year":"1998","unstructured":"Klein DN, Shih JH . Depressive personality: associations with DSM-III-R mood and personality disorders and negative and positive affectivity, 30-month stability, and prediction of course of Axis I depressive disorders J Abn Psychol 1998; 107: 319\u2013327","journal-title":"J Abn Psychol"},{"key":"BF4000697_CR38","first-page":"147","volume":"28","author":"KM Davidson","year":"1993","unstructured":"Davidson KM, Ritson FB . The relationship between alcohol dependence and depression Alcohol Alcohol 1993; 28: 147\u2013155","journal-title":"Alcohol Alcohol"},{"key":"BF4000697_CR39","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0376-8716(98)00095-7","volume":"52","author":"MT Lynskey","year":"1998","unstructured":"Lynskey MT . The comorbidity of alcohol dependence and affective disorders: treatment implications Drug Alcohol Depend 1998; 52: 201\u2013209","journal-title":"Drug Alcohol Depend"},{"key":"BF4000697_CR40","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3109\/00952999809019606","volume":"24","author":"SL Eames","year":"1998","unstructured":"Eames SL, Westermeyer J, Crosby RD . Substance use and abuse among patients with comorbid dysthymia and substance disorder Am J Drug Alcohol Abuse 1998; 24: 541\u2013550","journal-title":"Am J Drug Alcohol Abuse"},{"key":"BF4000697_CR41","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1176\/ajp.155.11.1556","volume":"155","author":"J Westermeyer","year":"1998","unstructured":"Westermeyer J, Eames SL, Nugent S . Comorbid dysthymia and substance disorder: treatment history and cost Am J Psychiatry 1998; 155: 1556\u20131560","journal-title":"Am J Psychiatry"},{"key":"BF4000697_CR42","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1176\/ajp.143.8.1042","volume":"143","author":"IW Miller","year":"1986","unstructured":"Miller IW, Norman WH, Dow MG . Psychosocial characteristics of \u2018double depression\u2019 Am J Psychiatry 1986; 143: 1042\u20131044","journal-title":"Am J Psychiatry"},{"key":"BF4000697_CR43","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/0165-0327(81)90031-8","volume":"3","author":"HS Akiskal","year":"1981","unstructured":"Akiskal HS, King D, Rosenthal TL, Robinson S, Scott-Strauss A . Chronic depressions, 1: clinical and familial characteristics in 137 probands J Affect Disord 1981; 3: 297\u2013315","journal-title":"J Affect Disord"},{"key":"BF4000697_CR44","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1515\/REVNEURO.1993.4.2.147","volume":"4","author":"H Anisman","year":"1993","unstructured":"Anisman H, Zalcman S, Zacharko RM . The impact of stressors on immune and central transmitter activity: bidirectional communication Rev Neurosci 1993; 4: 147\u2013180","journal-title":"Rev Neurosci"},{"key":"BF4000697_CR45","first-page":"69","volume-title":"Dysthymic Disorders","author":"RMA Hirschfeld","year":"1990","unstructured":"Hirschfeld RMA . Personality and dysthymia. In: Burton SW,Akiskal HS (eds) Dysthymic Disorders Gaskell: London 1990; pp69\u201377"},{"key":"BF4000697_CR46","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0165-0327(88)90068-7","volume":"14","author":"DN Klein","year":"1988","unstructured":"Klein DN, Taylor EB, Dickstein S, Harding K . The early-late onset distinction in DSM-III-R dysthymia J Affect Disord 1988; 14: 25\u201333","journal-title":"J Affect Disord"},{"key":"BF4000697_CR47","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1176\/ajp.144.12.1534","volume":"144","author":"JH Kocsis","year":"1987","unstructured":"Kocsis JH, Frances AJ . A critical discussion of DSM-III dysthymic disorder Am J Psychiatry 1987; 144: 1534\u20131542","journal-title":"Am J Psychiatry"},{"key":"BF4000697_CR48","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1097\/00005053-199009000-00004","volume":"178","author":"JP McCullough","year":"1990","unstructured":"McCullough JP, Braith, JA, Chapman RC, Kasnetz MD, Carr KF, Cones JH et al. Comparison of early and late onset dysthymia J Nerv Ment Dis 1990; 178: 577\u2013581","journal-title":"J Nerv Ment Dis"},{"key":"BF4000697_CR49","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/00005053-199801000-00009","volume":"186","author":"RA Sansone","year":"1998","unstructured":"Sansone RA, Wiederman MW, Sansone LA, Touchet B . Early-onset dysthymia and personality disturbance among patients in a primary care setting J Nerv Ment Dis 1998; 186: 57\u201358","journal-title":"J Nerv Ment Dis"},{"key":"BF4000697_CR50","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1037\/0021-843X.97.4.387","volume":"97","author":"DN Klein","year":"1988","unstructured":"Klein DN, Taylor EB, Dickstein S, Harding K . Primary early-onset dysthymia: comparison with primary non-bipolar non-chronic major depression on demographic, clinical, familial, personality, and socioenvironmental characteristics and short-term outcome J Abn Psychol 1988; 97: 387\u2013398","journal-title":"J Abn Psychol"},{"key":"BF4000697_CR51","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0165-0327(98)00163-3","volume":"52","author":"N Brunello","year":"1999","unstructured":"Brunello N, Akiskal H, Boyer P, Gessa GL, Howland RH, Langer SZ et al. Dysthymia: clinical picture, extent of overlap with chronic fatigue syndrome, neuropharmacological considerations, and new therapeutic vistas J Affect Disord 1999; 52: 275\u2013290","journal-title":"J Affect Disord"},{"key":"BF4000697_CR52","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/BF02599621","volume":"8","author":"E Walker","year":"1993","unstructured":"Walker E, Katon W, Jemelka R . Psychiatric disorders and medical care utilization among people who report fatigue in the general population J Gen Intern Med 1993; 8: 436\u2013440","journal-title":"J Gen Intern Med"},{"key":"BF4000697_CR53","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0033-3182(99)71272-7","volume":"40","author":"SA Epstein","year":"1999","unstructured":"Epstein SA, Kay G, Clauw D, Heaton R, Klein D, Krupp L et al. Psychiatric disorders in patients with fibromyalgia: a multicentre investigation Psychosomatics 1999; 40: 57\u201363","journal-title":"Psychosomatics"},{"key":"BF4000697_CR54","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s003930050246","volume":"57","author":"P Keel","year":"1998","unstructured":"Keel P . Psychological and psychiatric aspects of fibromyalgia syndrome (FMS) Z Rheumatol 1998; 57: 97\u2013100","journal-title":"Z Rheumatol"},{"key":"BF4000697_CR55","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/sj.mp.4000436","volume":"4","author":"H Anisman","year":"1999","unstructured":"Anisman H, Ravindran AV, Griffiths J, Merali Z . Behavioral, endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features Mol Psychiatry 1999; 4: 182\u2013188","journal-title":"Mol Psychiatry"},{"key":"BF4000697_CR56","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1023\/A:1027314713231","volume":"17","author":"JG Cannon","year":"1997","unstructured":"Cannon JG, Angel JB, Abad LW, Vannier E, Mileno MD, Fagioli L et al. Interleukin-1 beta, interleukin-1 receptor antagonist, and soluble interleukin-1 type II secretion in chronic fatigue syndrome J Clin Immunol 1997; 17: 253\u2013261","journal-title":"J Clin Immunol"},{"key":"BF4000697_CR57","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/1043-4666(91)90497-2","volume":"3","author":"CC Chao","year":"1991","unstructured":"Chao CC, Janoff EN, Hu SX, Thomas K, Gallagher M, Tsang M et al. Altered cytokine release in peripheral blood mononuclear cell cultures from patients with the chronic fatigue syndrome Cytokine 1991; 3: 292\u2013298","journal-title":"Cytokine"},{"key":"BF4000697_CR58","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1046\/j.1468-2982.1999.019004211.x","volume":"19","author":"DD Mitsikostas","year":"1999","unstructured":"Mitsikostas DD, Thomas AM . Comorbidity of headache and depressive disorders Cephalalgia 1999; 19: 211\u2013217","journal-title":"Cephalalgia"},{"key":"BF4000697_CR59","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0033-3182(99)71240-5","volume":"40","author":"A Okasha","year":"1999","unstructured":"Okasha A, Ismail MK, Khalil AH, EI Fiki R, Soliman A, Okasha T . A psychiatric study of nonorganic chronic headache patients Psychosomatics 1999; 40: 233\u2013238","journal-title":"Psychosomatics"},{"key":"BF4000697_CR60","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1046\/j.1468-2982.1999.1903159.x","volume":"19","author":"F Puca","year":"1999","unstructured":"Puca F, Genco S, Prudenzano MP, Savarese M, Bussone G, D\u2019 Amico D et al. Psychiatric comorbidity and psychosocial stress in patients with tension-type headache from headache centers in Italy Cephalalgia 1999; 19: 159\u2013164","journal-title":"Cephalalgia"},{"key":"BF4000697_CR61","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1212\/WNL.52.1.2","volume":"52","author":"W Poewe","year":"1999","unstructured":"Poewe W, Luginger E . Depression in Parkinson's disease: impediments to recognition and treatment options Neurology 1999; 52: S2\u2013S6","journal-title":"Neurology"},{"key":"BF4000697_CR62","first-page":"224","volume":"3","author":"CA Taylor","year":"1998","unstructured":"Taylor CA, Jung HY . Disorders of mood after traumatic brain injury Sem Clin Neuropsychiat 1998; 3: 224\u2013231","journal-title":"Sem Clin Neuropsychiat"},{"key":"BF4000697_CR63","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1469-7793.1999.003af.x","volume":"514","author":"NJ Rothwell","year":"1999","unstructured":"Rothwell NJ . Cytokines\u2014killers in the brain J Physiol 1999; 514: 3\u201317","journal-title":"J Physiol"},{"key":"BF4000697_CR64","first-page":"1223","volume-title":"Psychopharmacology: A Generation of Progress","author":"JJ Schildkraut","year":"1978","unstructured":"Schildkraut JJ . Current status of the catecholamine hypothesis of affective disorders. In: Lipton MA, DiMascio A, Killam KF (eds) Psychopharmacology: A Generation of Progress Raven Press: New York 1978; pp1223\u20131234"},{"key":"BF4000697_CR65","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1001\/archpsyc.1972.01750230084016","volume":"26","author":"A Coppen","year":"1972","unstructured":"Coppen A, Prange AJ Jr, Whybrow PC, Noguera R . Abnormalities of indolamines in affective disorders Arch Gen Psychiatry 1972; 26: 474\u2013478","journal-title":"Arch Gen Psychiatry"},{"key":"BF4000697_CR66","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/978-1-4684-3189-6_4","volume-title":"Handbook of Psychopharmacology","author":"HM van Praag","year":"1978","unstructured":"van Praag HM . Amine hypotheses of affective disorders. In: Iversen LL, Iversen SD, Snyder SH (eds) Handbook of Psychopharmacology Plenum: New York 1978; pp187\u2013298"},{"key":"BF4000697_CR67","first-page":"75","volume":"91","author":"AS Brown","year":"1993","unstructured":"Brown AS, Gershon S . Dopamine and depression J Neurotrans 1993; 91: 75\u2013109","journal-title":"J Neurotrans"},{"key":"BF4000697_CR68","first-page":"505","volume-title":"Psychopharmacology: The Third Generation of Progress","author":"DC Jimerson","year":"1987","unstructured":"Jimerson DC . Role of dopamine mechanisms in the affective disorders. In: Meltzer HY (ed) Psychopharmacology: The Third Generation of Progress Raven: New York 1987; pp505\u2013511"},{"key":"BF4000697_CR69","first-page":"493","volume-title":"Psychopharmacology: The Third Generation of Progress","author":"LJ Siever","year":"1987","unstructured":"Siever LJ . Role of noradrenergic mechanisms in the etiology of the affective disorders. In: Meltzer HY (ed) Psychopharmacology: The Third Generation of Progress Raven: New York 1987; pp493\u2013504"},{"key":"BF4000697_CR70","first-page":"269","volume-title":"Stimulants: Neurochemical, Behavioral and Clinical Perspectives","author":"SM Antelman","year":"1983","unstructured":"Antelman SM, Chiodo LA . Amphetamine as a stressor. In: Creese I (ed) Stimulants: Neurochemical, Behavioral and Clinical Perspectives Raven Press: New York 1983; pp269\u2013300"},{"key":"BF4000697_CR71","first-page":"513","volume-title":"Psychopharmacology: The Third Generation of Progress","author":"HY Meltzer","year":"1987","unstructured":"Meltzer HY, Lowy MT . The serotonin hypothesis of depression. In: Meltzer HY (ed) Psychopharmacology: The Third Generation of Progress Raven Press: New York 1987; pp513\u2013526"},{"key":"BF4000697_CR72","first-page":"249","volume-title":"Frontiers in Biochemical and Pharmacological Research in Depression","author":"F Sulser","year":"1984","unstructured":"Sulser F . Antidepressant treatments and regulation of norepinephrine-receptor-coupled adenylate cyclase systems in brain. In: Usdin E, Asberg M, Bertilsson L, Sjoqvist F (eds) Frontiers in Biochemical and Pharmacological Research in Depression Raven: New York 1984; pp249\u2013262"},{"key":"BF4000697_CR73","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1001\/archpsyc.1975.01760290025002","volume":"32","author":"JW Maas","year":"1975","unstructured":"Maas JW . Biogenic amines and depression Arch Gen Psychiatry 1975; 32: 1357\u20131361","journal-title":"Arch Gen Psychiatry"},{"key":"BF4000697_CR74","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1192\/S0007125000296633","volume":"160","author":"SA Checkley","year":"1992","unstructured":"Checkley SA . Neuroendocrine mechanisms and the precipitation of depression by life events Br J Psychiatry 1992; 160: 7\u201317","journal-title":"Br J Psychiatry"},{"key":"BF4000697_CR75","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0165-1781(92)90040-A","volume":"42","author":"RT Joffe","year":"1992","unstructured":"Joffe RT, Bagby RM, Levit AJ . The thyroid and melancholia Psychiatr Res 1992; 42: 73\u201380","journal-title":"Psychiatr Res"},{"key":"BF4000697_CR76","first-page":"311","volume-title":"Neurobiology of Mood Disorders","author":"AJ Prange","year":"1984","unstructured":"Prange AJ, Loosen PT, Wilson IC, Lipton MA . The therapeutic use of hormones of the thyroid axis in depression. In: Post RM, Ballenger JC (eds) Neurobiology of Mood Disorders Williams & Wilkins: Baltimore 1984; pp311\u2013322"},{"key":"BF4000697_CR77","first-page":"76","volume-title":"Biological Psychiatry: Recent Studies","author":"RT Rubin","year":"1984","unstructured":"Rubin RT, Poland RE . The dexamethasone suppression test in depression: advantages and limitation. In: Burrows GD, Norman TR, McGuire KP (eds) Biological Psychiatry: Recent Studies Libbey: London 1984; pp76\u201383"},{"key":"BF4000697_CR78","volume-title":"Life Events and Illness","author":"GW Brown","year":"1989","unstructured":"Brown GW, Harris TO . Life Events and Illness Guilford Press: New York 1989"},{"key":"BF4000697_CR79","volume-title":"Social Origins of Depression: A Study of Psychiatric Disorder in Women","author":"GW Brown","year":"1978","unstructured":"Brown GW, Harris TO . Social Origins of Depression: A Study of Psychiatric Disorder in Women Free Press: New York 1978"},{"key":"BF4000697_CR80","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1037\/0022-3514.54.5.847","volume":"54","author":"CJ Robins","year":"1988","unstructured":"Robins CJ, Block P . Personal vulnerability, life events, and depressive symptoms: a test of a specific interactional model J Pers Soc Psychol 1988; 54: 847\u2013852","journal-title":"J Pers Soc Psychol"},{"key":"BF4000697_CR81","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1037\/0021-843X.87.1.49","volume":"87","author":"LY Abramson","year":"1978","unstructured":"Abramson LY, Seligman MEP, Teasdale JD . Learned helplessness in humans: critique and reformulation J Abn Psychol 1978; 87: 49\u201374","journal-title":"J Abn Psychol"},{"key":"BF4000697_CR82","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1037\/0021-843X.101.2.234","volume":"2","author":"LB Alloy","year":"1992","unstructured":"Alloy LB, Clements CM . Illusion of control: invulnerability to negative affect and depressive symptoms after laboratory and natural stressors J Abn Psychol 1992; 2: 234\u2013245","journal-title":"J Abn Psychol"},{"key":"BF4000697_CR83","first-page":"1","volume-title":"Neuromethods, vol. 19: Animal Models of Psychiatry, II","author":"H Anisman","year":"1991","unstructured":"Anisman H, Zalcman S, Shanks N, Zacharko RM . Multisystem regulation of performance deficits induced by stressors: an animal model of depression. In: Boulton A, Baker G, Martin-Iverson M (eds) Neuromethods, vol. 19: Animal Models of Psychiatry, II Humana Press: New Jersey 1991; pp1\u201359"},{"key":"BF4000697_CR84","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/978-1-4684-6762-8_7","volume-title":"Animal Models of Depression","author":"JM Weiss","year":"1989","unstructured":"Weiss JM, Simson PE . Electrophysiology of the locus coeruleus: implications for stress-induced depression. In: Koob GF, Ehlers CL, Kupfer DJ (eds) Animal Models of Depression Birkhauser: Boston 1989; pp111\u2013134"},{"key":"BF4000697_CR85","first-page":"61","volume":"1","author":"R Heinsbroek","year":"1989","unstructured":"Heinsbroek R, van Haaren F, Feenstra M, van de Poll N . Changes in dopamine and noradrenaline activity in the frontal cortex produced by controllable and uncontrollable shock Behav Pharmacol 1989; 1: 61","journal-title":"Behav Pharmacol"},{"key":"BF4000697_CR86","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/ddr.430020106","volume":"2","author":"F Petty","year":"1982","unstructured":"Petty F, Sherman A . A neurochemical differentiation between exposure to stress and the development of learned helplessness Drug Devel Res 1982; 2: 43\u201345","journal-title":"Drug Devel Res"},{"key":"BF4000697_CR87","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/0006-8993(78)90144-0","volume":"152","author":"S Ritter","year":"1978","unstructured":"Ritter S, Pelzer NL . Magnitude of stress induced norepinephrine depletion varies with age Brain Res 1978; 152: 1701\u20131705","journal-title":"Brain Res"},{"key":"BF4000697_CR88","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0091-3057(82)90166-6","volume":"16","author":"M Tanaka","year":"1982","unstructured":"Tanaka M, Kohno Y, Nakagawa R et al. Time related differences in noradrenaline turnover in rat brain regions by stress Pharm Biochem Behav 1982; 16: 315\u2013319","journal-title":"Pharm Biochem Behav"},{"key":"BF4000697_CR89","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1037\/h0077603","volume":"93","author":"H Anisman","year":"1979","unstructured":"Anisman H, Sklar LS . Catecholamine depletion upon reexposure to stress: mediation of the escape deficits produced by inescapable shock J Comp Physiol Psychol 1979; 93: 610\u2013625","journal-title":"J Comp Physiol Psychol"},{"key":"BF4000697_CR90","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1126\/science.7403874","volume":"209","author":"G Cassens","year":"1980","unstructured":"Cassens G, Roffman M, Kuruc A, Orsulak PJ, Schildkraut JJ . Alterations of brain norepinephrine metabolism induced by environmental stimuli paired with inescapable shock Science 1980; 209: 1138\u20131140","journal-title":"Science"},{"key":"BF4000697_CR91","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/0006-8993(92)91639-V","volume":"586","author":"MD Doherty","year":"1992","unstructured":"Doherty MD, Gratton A . High-speed chronoamperometric measurements of mesolimbic and nigostriatal dopamine release associated with repeated daily stress Brain Res 1992; 586: 295\u2013302","journal-title":"Brain Res"},{"key":"BF4000697_CR92","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1016\/0024-3205(82)90295-8","volume":"30","author":"JP Herman","year":"1982","unstructured":"Herman JP, Guillonneau D, Dantzer R, Scatton B, Semerdjian-Rouquier L, LeMoal M . Differential effects of inescapable footshock and stimuli previously paired with inescapable footshocks on dopamine turnover in cortical and limbic areas of the rat Life Sci 1982; 30: 2207\u20132214","journal-title":"Life Sci"},{"key":"BF4000697_CR93","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/j.1749-6632.1988.tb42102.x","volume":"537","author":"RH Roth","year":"1988","unstructured":"Roth RH, Tam S-Y, Ida Y, Yang J-X, Deutch Y . Stress and mesocorticolimbic dopamine system Ann NY Acad Sci 1988; 537: 138\u2013147","journal-title":"Ann NY Acad Sci"},{"key":"BF4000697_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ddr.430140102","volume":"14","author":"SM Antelman","year":"1988","unstructured":"Antelman SM . Time-dependent sensitization as the cornerstone for a new approach to pharmacotherapy: drugs as foreign\/stressful stimuli Drug Dev Res 1988; 14: 1\u201330","journal-title":"Drug Dev Res"},{"key":"BF4000697_CR95","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1471-4159.1992.tb09307.x","volume":"58","author":"LK Nisenbaum","year":"1992","unstructured":"Nisenbaum LK, Abercrombie ED . Enhanced tyrosine hydroxylation in hippocampus of chronically stressed rats upon exposure to a novel stressor J Neurochem 1992; 58: 276\u2013281","journal-title":"J Neurochem"},{"key":"BF4000697_CR96","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1523\/JNEUROSCI.11-05-01478.1991","volume":"11","author":"LK Nisenbaum","year":"1991","unstructured":"Nisenbaum LK, Zigmond MJ, Sved AF, Abercrombie ED . Prior exposure to chronic stress results in enhanced synthesis and release of hippocampal norepinephrine in response to a novel stressor J Neurosci 1991; 11: 1478\u20131484","journal-title":"J Neurosci"},{"key":"BF4000697_CR97","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0079-6123(08)62691-6","volume":"85","author":"AY Deutch","year":"1990","unstructured":"Deutch AY, Roth RH . The determinants of stress-induced activation of the prefrontal cortical dopamine system Prog Brain Res 1990; 85: 367\u2013402","journal-title":"Prog Brain Res"},{"key":"BF4000697_CR98","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/BF00555227","volume":"84","author":"JP Herman","year":"1984","unstructured":"Herman JP, Stinus L, Le Moal M . Repeated stress increases locomotor response to amphetamine Psychopharmacology 1984; 84: 431\u2013435","journal-title":"Psychopharmacology"},{"key":"BF4000697_CR99","first-page":"983","volume-title":"Psychopharmacology: The Fourth Generation of Progress","author":"M Irwin","year":"1995","unstructured":"Irwin M . Psychoneuroimmunology of depression. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: The Fourth Generation of Progress Raven Press: New York 1995; pp983\u2013998"},{"key":"BF4000697_CR100","first-page":"7","volume-title":"Catecholamines and Stress: Recent Advances","author":"R Kvetnansky","year":"1980","unstructured":"Kvetnansky R . Recent progress in catecholamines under stress. In: Usdin E, Kvetnansky R, Kopin IJ (eds) Catecholamines and Stress: Recent Advances Elsevier: New York 1980; pp7\u201320"},{"key":"BF4000697_CR101","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/978-1-4684-6762-8_11","volume-title":"Animal Models of Depression","author":"RM Zacharko","year":"1989","unstructured":"Zacharko RM, Anisman H . Pharmacological, biochemical and behavioral analyses of depression: animal models. In: Koob GF, Ehlers CL, Kupfer DJ (eds) Animal Models of Depression Birkhauser: Boston 1989; 204\u2013238"},{"key":"BF4000697_CR102","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0149-7634(87)80009-X","volume":"11","author":"EA Stone","year":"1987","unstructured":"Stone EA . Central cyclic-AMP-linked noradrenergic receptors: new findings on properties as related to the actions of stress Neurosci Biobehav Rev 1987; 11: 391\u2013398","journal-title":"Neurosci Biobehav Rev"},{"key":"BF4000697_CR103","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0091-3057(90)90165-E","volume":"35","author":"VA Molina","year":"1990","unstructured":"Molina VA, Volosin M, Cancela L, Keller E, Murua VS, Basso AM . Effect of chronic variable stress on monoamine receptors: influence of imipramine administration Pharmacol Biochem Behav 1990; 35: 335\u2013340","journal-title":"Pharmacol Biochem Behav"},{"key":"BF4000697_CR104","first-page":"77","volume":"1","author":"P Willner","year":"1987","unstructured":"Willner P . The anatomy of melancholy: the catecholamine hypothesis of depression revisted Rev Neurosci 1987; 1: 77\u201399","journal-title":"Rev Neurosci"},{"key":"BF4000697_CR105","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s002130050457","volume":"134","author":"H Anisman","year":"1997","unstructured":"Anisman H, Merali Z . Chronic stressors and animal models of depression: distinguishing characteristics and individual profiles Psychopharmacology 1997; 134: 330\u2013332","journal-title":"Psychopharmacology"},{"key":"BF4000697_CR106","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0306-4530(97)00099-1","volume":"23","author":"J Schulkin","year":"1998","unstructured":"Schulkin J, Gold PW, McEwen BS . Induction of corticotropin-releasing hormone gene expression by glucocorticoids: implication for understanding the states of fear and anxiety and allostatic load Psychoneuroendocrinology 1998; 23: 219\u2013243","journal-title":"Psychoneuroendocrinology"},{"key":"BF4000697_CR107","first-page":"957","volume-title":"Psychopharmacology: The Fourth Generation of Progress","author":"F Holsboer","year":"1995","unstructured":"Holsboer F . Neuroendocrinology of mood disorders. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: The Fourth Generation of Progress Raven Press: New York 1995; pp957\u2013969"},{"key":"BF4000697_CR108","first-page":"933","volume-title":"Psychopharmacology: The Fourth Generation of Progress","author":"M Maes","year":"1995","unstructured":"Maes M, Meltzer HY . The serotonin hypothesis of major depression. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: The Fourth Generation of Progress Raven Press: New York 1995; pp933\u2013944"},{"key":"BF4000697_CR109","first-page":"971","volume-title":"Psychopharmacology: The Fourth Generation of Progress","author":"PM Plotsky","year":"1995","unstructured":"Plotsky PM, Owens MJ, Nemeroff CB . Neuropeptide alterations in mood disorders. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: The Fourth Generation of Progress Raven Press: New York 1995; pp971\u2013981"},{"key":"BF4000697_CR110","first-page":"911","volume-title":"Psychopharmacology: The Fourth Generation of Progress","author":"AF Schatzberg","year":"1995","unstructured":"Schatzberg AF, Schildkraut JJ . Recent studies on norepinephrine systems on mood disorders. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: The Fourth Generation of Progress Raven: New York 1995; pp911\u2013920"},{"key":"BF4000697_CR111","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/0165-0327(94)90114-7","volume":"31","author":"AV Ravindran","year":"1994","unstructured":"Ravindran AV, Bialik RJ, Lapierre YD . Primary early onset dysthymia, biochemical correlates of the therapeutic response to fluoxetine: 1. Platelet monoamine oxidase and the dexamethasone suppression test J Affect Disord 1994; 31: 111\u2013117","journal-title":"J Affect Disord"},{"key":"BF4000697_CR112","first-page":"67","volume":"9","author":"LMC Jansen","year":"1999","unstructured":"Jansen LMC, Gispen-de Wied CC, Jansen MA, van der Gaag RJ, Matthys W, van Engeland H . Pituitary-adrenal reactivity in a child psychiatric population: salivary cortisol response to stressors Eur Psychopharmacol 1999; 9: 67\u201375","journal-title":"Eur Psychopharmacol"},{"key":"BF4000697_CR113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0165-0327(94)90055-8","volume":"32","author":"E Szadoczky","year":"1994","unstructured":"Szadoczky E, Sazekas I, Rihmer Z, Arato M . The role of psychosocial and biological variables in separating chronic and non-chronic major depression and early-late onset dysthymia J Affect Disord 1994; 32: 1\u201311","journal-title":"J Affect Disord"},{"key":"BF4000697_CR114","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/00004850-199707000-00001","volume":"12","author":"M Versiani","year":"1997","unstructured":"Versiani M, Amrein R, Stabl M, the International Collaborative Study Group . Moclobemide and imipramine in chronic depression (dysthymia): an international double-blind, placebo-controlled trial Int Clin Psychopharm 1997; 12: 183\u2013193","journal-title":"Int Clin Psychopharm"},{"key":"BF4000697_CR115","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/0006-3223(94)00220-W","volume":"37","author":"F Lechin","year":"1994","unstructured":"Lechin F, van der Dijs B, Orozco B, Lechin AE . Plasma neurotransmitters, blood pressure, and heart rate during supine resting, orthostasis, and moderate exercise in dysthymic depressed patients Biol Psychiatry 1994; 37: 884\u2013891","journal-title":"Biol Psychiatry"},{"key":"BF4000697_CR116","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0165-0327(95)00043-M","volume":"35","author":"B Wahlund","year":"1995","unstructured":"Wahlund B, Saaf J, Wetterberg L . Clinical symptoms and platelet monoamine oxidase in subgroups and different states of affective disorders J Affect Disord 1995; 35: 75\u201387","journal-title":"J Affect Disord"},{"key":"BF4000697_CR117","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0165-0327(94)90115-5","volume":"31","author":"AV Ravindran","year":"1994","unstructured":"Ravindran AV, Bialik RJ, Brown GM, Lapierre YD . Primary early onset dysthymia, biochemical correlates of the therapeutic response to fluoxetine: II. Urinary metabolites of serotonin, norepinephrine, epinephrine and melatonin J Affect Disord 1994; 31: 119\u2013123","journal-title":"J Affect Disord"},{"key":"BF4000697_CR118","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1037\/0021-843X.103.4.625","volume":"103","author":"CM Yee","year":"1994","unstructured":"Yee CM, Miller GA . A dual-task analysis of resource allocation in dysthymia and anhedonia J Abn Psychol 1994; 103: 625\u2013636","journal-title":"J Abn Psychol"},{"key":"BF4000697_CR119","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1037\/0021-843X.101.2.230","volume":"101","author":"CM Yee","year":"1992","unstructured":"Yee CM, Deldin PJ, Miller GA . Early stimulus processing in dysthymia and anhedonia J Abn Psychol 1992; 101: 230\u2013233","journal-title":"J Abn Psychol"},{"key":"BF4000697_CR120","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0165-0327(84)80007-5","volume":"6","author":"HS Akiskal","year":"1984","unstructured":"Akiskal HS, Lemmi H, Dickson H, King D, Yerevanian B, Van Valkenberg C . Chronic depressions. Part 2. Sleep EEG differentiation of primary dysthymic disorders from anxious depressions J Affect Disord 1984; 6: 287\u2013295","journal-title":"J Affect Disord"},{"key":"BF4000697_CR121","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1001\/archpsyc.1980.01780200055006","volume":"37","author":"HS Akiskal","year":"1980","unstructured":"Akiskal HS, Rosenthal TL, Haykal RF, Lemmi H, Rosenthal RT, Scott-Strauss A . Characterological depressions: clinical and sleep EEG findings separating \u2018subaffective dysthymias\u2019 from \u2018character spectrum\u2019 disorders Arch Gen Psychiatry 1980; 37: 777\u2013783","journal-title":"Arch Gen Psychiatry"},{"key":"BF4000697_CR122","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0165-0327(97)00059-1","volume":"45","author":"HS Akiskal","year":"1997","unstructured":"Akiskal HS, Judd LL, Gillin C, Lemmi H . Subthreshold depressions: clinical and polysomnographic validation of dysthymic, residual and masked forms J Affect Disord 1997; 45: 53\u201363","journal-title":"J Affect Disord"},{"key":"BF4000697_CR123","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1159\/000119225","volume":"32","author":"F Arriaga","year":"1995","unstructured":"Arriaga F, Cavaglia F, Matospires A, Lara E, Paiva T . EEG sleep characteristics in dysthymia and major depressive disorder Neuropsychobiology 1995; 32: 128\u2013131","journal-title":"Neuropsychobiology"},{"key":"BF4000697_CR124","doi-asserted-by":"publisher","first-page":"422","DOI":"10.2165\/00023210-199504060-00005","volume":"4","author":"D Baldwin","year":"1995","unstructured":"Baldwin D, Rudge S, Thomas S . Dysthymia: options in pharmacotherapy CNS Drugs 1995; 4: 422\u2013431","journal-title":"CNS Drugs"},{"key":"BF4000697_CR125","first-page":"58","volume":"46","author":"HR Conte","year":"1992","unstructured":"Conte HR, Karasu TB . A review of treatment studies of minor depression: 1980\u20131991 Am J Psychiatry 1992; 46: 58\u201374","journal-title":"Am J Psychiatry"},{"key":"BF4000697_CR126","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/(SICI)1520-6394(1998)8:1+<54::AID-DA8>3.0.CO;2-5","volume":"8","author":"DL Dunner","year":"1998","unstructured":"Dunner DL . Treatment of dysthymic disorder Depress Anxiety 1998; 8: 54\u201358","journal-title":"Depress Anxiety"},{"key":"BF4000697_CR127","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1146\/annurev.med.50.1.453","volume":"50","author":"E Frank","year":"1999","unstructured":"Frank E, Thase ME . Natural history and preventative treatment of recurrent mood disorders Ann Rev Med 1999; 50: 453\u2013468","journal-title":"Ann Rev Med"},{"key":"BF4000697_CR128","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4088\/JCP.v60n0107","volume":"60","author":"JM Gorman","year":"1999","unstructured":"Gorman JM, Kent JM . SSRIs and SNRIs: broad spectrum of efficacy beyond major depression J Clin Psychiatry 1999; 60: 33\u201338","journal-title":"J Clin Psychiatry"},{"issue":"suppl 383","key":"BF4000697_CR129","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1600-0447.1994.tb05878.x","volume":"89","author":"JJ Lopez Ibor","year":"1994","unstructured":"Lopez Ibor JJ, Frances A, Jones C . Dysthymic disorder: a comparison of DSM-IV and ICD-10 and issues in differential diagnosis Acta Psychiatr Scand 1994; 89: (suppl 383) 12\u201318","journal-title":"Acta Psychiatr Scand"},{"key":"BF4000697_CR130","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1001\/archpsyc.1985.01790350022005","volume":"42","author":"JW Stewart","year":"1985","unstructured":"Stewart JW, McGrath PJ, Liebowitz MR . Treatment outcome validation of DSM-III depressive subtypes: clinical usefulness in outpatients with mild to moderate depression Arch Gen Psychiatry 1985; 42: 1148\u20131153","journal-title":"Arch Gen Psychiatry"},{"key":"BF4000697_CR131","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0165-0327(95)00003-6","volume":"34","author":"RA Friedman","year":"1995","unstructured":"Friedman RA, Markowitz JC, Parides M, Kocsis JH . Acute response of social functioning in dysthymic patients with desipramine J Affect Disord 1995; 34: 85\u201388","journal-title":"J Affect Disord"},{"key":"BF4000697_CR132","doi-asserted-by":"publisher","first-page":"598","DOI":"10.4088\/JCP.v59n1107","volume":"59","author":"MB Keller","year":"1998","unstructured":"Keller MB, Gelengerg AJ, Hirschfeld RN, Rush AJ, Thase ME, Kocsis JH et al. The treatment of chronic depression, part 2: a double blind, randomized trial of sertraline and imipramine J Clin Psychiatry 1998; 59: 598\u2013607","journal-title":"J Clin Psychiatry"},{"key":"BF4000697_CR133","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1001\/archpsyc.1988.01800270071008","volume":"45","author":"JH Kocsis","year":"1988","unstructured":"Kocsis JH, Frances AJ, Voss C, Mann JJ, Mason BJ, Sweeney J . Imipramine treatment for chronic depression Arch Gen Psychiatry 1988; 45: 253\u2013257","journal-title":"Arch Gen Psychiatry"},{"issue":"suppl 3","key":"BF4000697_CR134","doi-asserted-by":"publisher","first-page":"S204","DOI":"10.1016\/0924-977X(94)90039-6","volume":"4","author":"JH Kocsis","year":"1994","unstructured":"Kocsis JH, Thase M, Koran L, Halbreich U, Yonkers K . Pharmacotherapy of pure dysthymia: sertraline vs imipramine and placebo Eur Neuropsychopharm 1994; 4: (suppl 3) S204","journal-title":"Eur Neuropsychopharm"},{"key":"BF4000697_CR135","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1176\/ajp.151.7.1079","volume":"151","author":"DB Marin","year":"1994","unstructured":"Marin DB, Kocsis JH, Frances AJ, Parides M . Desipramine for the treatment of \u2018pure\u2019 dysthymia versus \u2018double\u2019 depression Am J Psychiatry 1994; 151: 1079\u20131080","journal-title":"Am J Psychiatry"},{"key":"BF4000697_CR136","first-page":"391","volume":"13","author":"JW Stewart","year":"1993","unstructured":"Stewart JW, McGrath PJ, Quitkin FM, Rabkin J, Harrison W, Wager S et al. Chronic depression: response to placebo, imipramine, and phenelzine J Clin Psychopharmacol 1993; 13: 391\u2013396","journal-title":"J Clin Psychopharmacol"},{"issue":"suppl 1","key":"BF4000697_CR137","first-page":"148b","volume":"15","author":"M Versiani","year":"1992","unstructured":"Versiani M, Nardi D, Capponi R, Costa DA, Magistris H, Ucha Udabe R . Moclobemide compared with imipramine in the treatment of chronic depression (dysthymia DSM-III-R): a double-blind placebo-controlled trial Clin Neuropharmacol 1992; 15: (suppl 1) 148b","journal-title":"Clin Neuropharmacol"},{"issue":"suppl 386","key":"BF4000697_CR138","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1600-0447.1995.tb05922.x","volume":"91","author":"H Petursson","year":"1995","unstructured":"Petursson H . Studies of reversible and selective inhibitors of monoamine oxidase A in dysthymia Acta Psychiatr Scand 1995; 91: (suppl 386) 36\u201339","journal-title":"Acta Psychiatr Scand"},{"key":"BF4000697_CR139","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1192\/bjp.151.5.639","volume":"151","author":"J Vallejo","year":"1987","unstructured":"Vallejo J, Gasto C, Catalan R, Salamero M . Double blind study of imipramine versus phenelzine in melancholias and dysthymic disorders Br J Psychiatry 1987; 151: 639\u2013642","journal-title":"Br J Psychiatry"},{"key":"BF4000697_CR140","doi-asserted-by":"crossref","unstructured":"Baumhackl U, Biziere K, Fischbach R, Geretsegger C, Hebenstreit G, Radmayr E et al. Efficacy and tolerability of moclobemide compared with imipramine in depressive disorder (DSM-III): an Austrian double-blind multicentre study Br J Psychiatry 1989; suppl 6: 78\u201383","DOI":"10.1192\/S0007125000297535"},{"key":"BF4000697_CR141","first-page":"355","volume":"92","author":"L Botte","year":"1992","unstructured":"Botte L, Evrard JL, Gilles C, Stenier P, Wolfrum C . Controlled comparison of RO 11\u20131163 (mocobemide) and placebo I the treatment of depression Acta Psychiat Belg 1992; 92: 355\u2013369","journal-title":"Acta Psychiat Belg"},{"key":"BF4000697_CR142","volume-title":"Moclobemide versus fluoxetine in the treatment of dysthmia","author":"A Duarte","year":"1993","unstructured":"Duarte A, Camozzi CR . Moclobemide versus fluoxetine in the treatment of dysthmia 9th World Congress of Psychiatry abstract, Rio de Janeiro 1993"},{"issue":"3S","key":"BF4000697_CR143","first-page":"298","volume":"10","author":"M Versiani","year":"1993","unstructured":"Versiani M . Pharmacotherapy of dysthymia: a controlled study with imipramine, moclobemide or placebo Neuropsychopharmacology 1993; 10: (3S) 298","journal-title":"Neuropsychopharmacology"},{"key":"BF4000697_CR144","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1176\/ajp.150.8.1169","volume":"150","author":"DJ Hellerstein","year":"1993","unstructured":"Hellerstein DJ, Yanowitch P, Rosenthal J, Samstag LW, Maurer M, Dasch K et al. A randomized double blind study of fluoxetine versus placebo in the treatment of dysthymia Am J Psychiatry 1993; 150: 1169\u20131175","journal-title":"Am J Psychiatry"},{"key":"BF4000697_CR145","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1001\/archpsyc.1996.01830090023004","volume":"53","author":"ME Thase","year":"1996","unstructured":"Thase ME, Fava M, Halbreich U, Kocsis JH, Koran L, Davidson J et al. A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia Arch Gen Psychiatry 1996; 53: 777\u2013784","journal-title":"Arch Gen Psychiatry"},{"key":"BF4000697_CR146","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1192\/bjp.170.4.345","volume":"170","author":"JM Vanelle","year":"1997","unstructured":"Vanelle JM, Attar-Levy D, Poirier MF, Bouhassira M, Blin P, Olie JP . Controlled efficacy study of fluoxetine in dysthymia Br J Psychiatry 1997; 170: 345\u2013350","journal-title":"Br J Psychiatry"},{"key":"BF4000697_CR147","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/00004714-199312000-00006","volume":"13","author":"D Bakish","year":"1993","unstructured":"Bakish D, Lapierre YD, Weinstein R, Klein J, Wiens A, Jones B et al. Ritanserin, imipramine and placebo in the treatment of dysthymic disorder J Clin Psychopharmacol 1993; 13: 409\u2013414","journal-title":"J Clin Psychopharmacol"},{"key":"BF4000697_CR148","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1600-0447.1991.tb05533.x","volume":"83","author":"G Bersani","year":"1991","unstructured":"Bersani G, Pozzi F, Marini S, Grispini A, Pasini A, Ciani N . 5-HT2 receptor antagonism in dysthymic disorder: a double-blind placebo-controlled study with ritanserin Acta Psychiatr Scand 1991; 83: 244\u2013248","journal-title":"Acta Psychiatr Scand"},{"key":"BF4000697_CR149","first-page":"4","volume":"59","author":"GD Burrows","year":"1998","unstructured":"Burrows GD, Maguire KP, Norman TR . Antidepressant efficacy and tolerability of the selective norepinephrine reuptake inhibitor reboxetine: a review J Clin Psychiatry 1998; 59: 4\u20137","journal-title":"J Clin Psychiatry"},{"key":"BF4000697_CR150","doi-asserted-by":"publisher","first-page":"528","DOI":"10.4088\/JCP.v58n1203","volume":"58","author":"DL Dunner","year":"1997","unstructured":"Dunner DL, Hendrickson HE, Bea C, Budech CB . Venlafaxine in dysthymic disorder J Clin Psychiat 1997; 58: 528\u2013531","journal-title":"J Clin Psychiat"},{"key":"BF4000697_CR151","first-page":"288","volume":"23","author":"AV Ravindran","year":"1998","unstructured":"Ravindran AV, Charbonneau Y, Zaharia M, Al-Zaid K, Wiens A, Anisman H . Efficacy and tolerability of venlafaxine in the treatment of primary dysthymia J Psychiat Neurosci 1998; 23: 288\u2013292","journal-title":"J Psychiat Neurosci"},{"key":"BF4000697_CR152","first-page":"346","volume":"47","author":"W Harrison","year":"1986","unstructured":"Harrison W, Rabkin J, Stewart JW, McGrath PJ, Tricamo E, Quitkin F . Phenelzine for chronic depressions: a study of continuation treatment J Clin Psychiatry 1986; 47: 346\u2013349","journal-title":"J Clin Psychiatry"},{"key":"BF4000697_CR153","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0140-6736(88)92535-4","volume":"8605","author":"P Tyrer","year":"1988","unstructured":"Tyrer P, Seivewright N, Murphy S, Ferguson B, Kingdon D, Barczak P et al. The Nottingham study of neurotic disorder: comparison of drug and psychological treatments Lancet 1988; 8605: 235\u2013240","journal-title":"Lancet"},{"key":"BF4000697_CR154","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1001\/archpsyc.1989.01810120022005","volume":"46","author":"JW Stewart","year":"1989","unstructured":"Stewart JW, McGrath PJ, Quitkin FM, Harrison W, Markowitz J, Wager S et al. Relevance of DSM-III depressive subtype and chronicity to antidepressant efficacy in atypical depression: differential response to phenelzine, imipramine, and placebo Arch Gen Psychiatry 1989; 46: 1080\u20131087","journal-title":"Arch Gen Psychiatry"},{"key":"BF4000697_CR155","first-page":"242","volume":"5","author":"JA Costa-e-Silva","year":"1990","unstructured":"Costa-e-Silva JA . Treatment of dysthymic disorder with low-dose amisulpride. A comparative study of 50mg\/day amisulpride versus placebo Ann Psychiatry 1990; 5: 242\u2013249","journal-title":"Ann Psychiatry"},{"key":"BF4000697_CR156","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0165-0327(96)00103-6","volume":"43","author":"Y Lecrubier","year":"1997","unstructured":"Lecrubier Y, Boyer P, Turjanski S, Rein W, the Amisulpride Study Group . Amisulpride versus imipramine and placebo in dysthymia and major depression J Affect Disord 1997; 43: 95\u2013103","journal-title":"J Affect Disord"},{"key":"BF4000697_CR157","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000026556","volume":"39","author":"P Boyer","year":"1999","unstructured":"Boyer P, Lecrubier Y, Stalla-Bourdillon A, Fleurot O . Amisulpride versus amineptine and placebo for the treatment of dysthymia Neuropsychobiology 1999; 39: 25\u201332","journal-title":"Neuropsychobiology"},{"key":"BF4000697_CR158","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1177\/070674379403900106","volume":"39","author":"AV Ravindran","year":"1994","unstructured":"Ravindran AV, Bialik RJ, Lapierre YD . Therapeutic efficacy of specific serotonin reuptake inhibitors (SSRIs) in dysthymia Can J Psychiatry 1994; 39: 21\u201326","journal-title":"Can J Psychiatry"},{"key":"BF4000697_CR159","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/00004714-199508000-00007","volume":"15","author":"RA Friedman","year":"1995","unstructured":"Friedman RA, Parides M, Baff R, Moran M, Kocsis JH . Predictors of response to desipramine in dysthymia J Clin Psychopharm 1995; 15: 280\u2013283","journal-title":"J Clin Psychopharm"},{"key":"BF4000697_CR160","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1001\/archpsyc.1996.01830090013002","volume":"53","author":"JH Kocsis","year":"1996","unstructured":"Kocsis JH, Friedman RA, Markowitz JC, Leon AC, Miller NL, Gniwesch L et al. Maintenance therapy for chronic depression. A controlled clinical trial of desipramine Arch Gen Psychiatry 1996; 53: 769\u2013774","journal-title":"Arch Gen Psychiatry"},{"key":"BF4000697_CR161","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1055\/s-2007-979314","volume":"31","author":"G Santagostino","year":"1998","unstructured":"Santagostino G, Cucchi ML, Frattini P, Zerbi F, Di Paolo E, Preda S et al. The influence of alprazolam on the monoaminergic neurotransmitter systems in dysthymic patients. Relationship to clinical response Pharmacopsychiatry 1998; 31: 131\u2013136","journal-title":"Pharmacopsychiatry"},{"key":"BF4000697_CR162","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0165-0327(97)00139-0","volume":"48","author":"E Smeraldi","year":"1998","unstructured":"Smeraldi E . Amisulpride versus fluoxetine in patients with dysthymia or major depression in partial remission. A double-blind, comparative study J Affect Disord 1998; 48: 47\u201356","journal-title":"J Affect Disord"},{"key":"BF4000697_CR163","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/S0006-3223(99)00066-9","volume":"45","author":"M Bloch","year":"1999","unstructured":"Bloch M, Schmidt PJ, Danaceau MA, Adams LF, Rubinow DR . Dehydroepiandrosterone treatment of midlife dysthymia Biol Psychiatry 1999; 45: 1533\u20131541","journal-title":"Biol Psychiatry"},{"key":"BF4000697_CR164","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0006-3223(98)00033-X","volume":"45","author":"S Rudas","year":"1999","unstructured":"Rudas S, Schmitz M, Pichler P, Baumgartner A . Treatment of refractory chronic depression and dysthymia with high-dose thyroxin Biol Psychiatry 1999; 45: 229\u2013233","journal-title":"Biol Psychiatry"},{"key":"BF4000697_CR165","doi-asserted-by":"publisher","first-page":"237","DOI":"10.4088\/JCP.v60n0406","volume":"60","author":"MN McCleod","year":"1999","unstructured":"McCleod MN, Gaynes BN, Golden RN . Chromium potentiation of antidepressant pharmacotherapy for dysthymic disorder in 5 patients J Clin Psychiatry 1999; 60: 237\u2013240","journal-title":"J Clin Psychiatry"},{"key":"BF4000697_CR166","first-page":"56","volume":"52","author":"JH Kocsis","year":"1991","unstructured":"Kocsis JH, Sutton BM, Frances AJ . Long-term follow-up of chronic depression treated with imipramine J Clin Psychiatry 1991; 52: 56\u201359","journal-title":"J Clin Psychiatry"},{"key":"BF4000697_CR167","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/0278-5846(96)00007-3","volume":"20","author":"DJ Hellerstein","year":"1996","unstructured":"Hellerstein DJ, Samstag LW, Cantillon M, Maurer M, Rosenthal J, Yanowitch P et al. Follow-up assessment of medication-treated dysthymia Prog Neuro-Psychopharmacol Biol Psychiatry 1996; 20: 427\u2013442","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"BF4000697_CR168","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1017\/S0140525X00020306","volume":"8","author":"RA Wise","year":"1985","unstructured":"Wise RA . The anhedonia hypothesis: mark III Behav Brain Sci 1985; 8: 178\u2013186","journal-title":"Behav Brain Sci"},{"key":"BF4000697_CR169","first-page":"pp1","volume-title":"Depression and Mania: From Neurobiology to Treatment","author":"HC Fibiger","year":"1995","unstructured":"Fibiger HC . Neurobiology of depression: focus on dopamine. In: Gessa GL, Fratta W, Pani L, Serra G (eds) Depression and Mania: From Neurobiology to Treatment Lippincott-Raven: Philadelphia 1995; pp1\u201342"},{"key":"BF4000697_CR170","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0006-3223(92)90137-O","volume":"32","author":"S Kapur","year":"1992","unstructured":"Kapur S, Mann JJ . Role of the dopaminergic system in depression Biol Psychiatry 1992; 32: 1\u201317","journal-title":"Biol Psychiatry"},{"key":"BF4000697_CR171","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/BF02245573","volume":"115","author":"W Maier","year":"1994","unstructured":"Maier W, Benkert O . Treatment of chronic depression with sulpiride: evidence of efficacy in placebo-controlled single case studies Psychopharmacology 1994; 115: 495\u2013501","journal-title":"Psychopharmacology"},{"key":"BF4000697_CR172","first-page":"41","volume":"40","author":"CA Leon","year":"1994","unstructured":"Leon CA, Vigoya J, Conde S, Campo G, Castrillon E, Leon A . Comparison of the effect of amisulpride and viloxazine in the treatment of dysthymia Acta Psiquiatr Psicol Am Lat 1994; 40: 41\u201349","journal-title":"Acta Psiquiatr Psicol Am Lat"},{"key":"BF4000697_CR173","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1001\/archpsyc.1994.03950050043005","volume":"51","author":"RB Goldstein","year":"1994","unstructured":"Goldstein RB, Weissman MM, Adams PB, Horwath E, Lish JD, Charney D et al. Psychiatric disorders in relatives of probands with panic disorder and\/or major depression Arch Gen Psychiatry 1994; 51: 383\u2013394","journal-title":"Arch Gen Psychiatry"},{"key":"BF4000697_CR174","first-page":"103","volume-title":"Diagnosis and Treatment of Chronic Depression","author":"DW Goodman","year":"1995","unstructured":"Goodman DW, Barnhill J . Family and genetic epidemiologic studies. In: Kocsis JH, Klein DN (eds) Diagnosis and Treatment of Chronic Depression Guilford Press: New York 1995; pp103\u2013123"},{"key":"BF4000697_CR175","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1001\/archpsyc.1995.03950180073010","volume":"52","author":"DN Klein","year":"1995","unstructured":"Klein DN, Riso LP, Donaldson SK, Schwartz JE, Anderson RL, Ouimette PL et al. Family study of early-onset dysthymia. Mood and personality disorders in relatives of outpatients with dysthymia and episodic major depression and normal controls Arch Gen Psychiatry 1995; 52: 487\u2013496","journal-title":"Arch Gen Psychiatry"},{"key":"BF4000697_CR176","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0165-0327(96)00106-1","volume":"42","author":"SK Donaldson","year":"1997","unstructured":"Donaldson SK, Klein DN, Riso LP, Schwartz JE . Comorbidity between dysthymic and major depressive disorders: a family study analysis J Affect Disord 1997; 42: 103\u2013111","journal-title":"J Affect Disord"},{"key":"BF4000697_CR177","first-page":"222","volume":"Vol 16. Springe","author":"DN Klein","year":"1993","unstructured":"Klein DN, Riso LP, Anderson RL . DSM-III-R dysthymia: antecedents and underlying assumptions. In: Chapman LJ, Chapman JP, Fowles DC (eds) Progress in Experimental Personality and Psychopathology Research Vol 16. Springer: New York: 1993; pp222\u2013253","journal-title":"Progress in Experimental Personality and Psychopathology Research"},{"key":"BF4000697_CR178","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1176\/ajp.153.7.900","volume":"153","author":"LP Riso","year":"1996","unstructured":"Riso LP, Klein DN, Ferro T, Kasch KL, Pepper CM, Schwartz JE et al. Understanding the comorbidity between early-onset dysthymia and cluster B personality disorders: a family study Am J Psychiatry 1996; 153: 900\u2013906","journal-title":"Am J Psychiatry"},{"key":"BF4000697_CR179","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1097\/00001756-199805110-00009","volume":"9","author":"K Ohara","year":"1998","unstructured":"Ohara K, Nagai M, Suzuki Y, Ohara K . Low activity allele of catechol-o-methyltransferase gene and Japanese unipolar depression NeuroReport 1998; 9: 1305\u20131308","journal-title":"NeuroReport"},{"key":"BF4000697_CR180","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1001\/archpsyc.55.5.468","volume":"55","author":"MJ Lyons","year":"1998","unstructured":"Lyons MJ, Eisen SA, Goldberg J, True W, Lin N, Meyer JM et al. A registry-based twin study of depression in men Arch Gen Psychiatry 1998; 55: 468\u2013472","journal-title":"Arch Gen Psychiatry"},{"key":"BF4000697_CR181","first-page":"101","volume-title":"Psychosocial Aspects of Depression","author":"SM Monroe","year":"1991","unstructured":"Monroe SM, Depue RA . Life stress and depression. In: Becker J, Kleinman A (eds) Psychosocial Aspects of Depression Erlbaum: Hillsdale 1991; pp101\u2013130"},{"key":"BF4000697_CR182","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1037\/0033-2909.110.3.406","volume":"110","author":"SM Monroe","year":"1991","unstructured":"Monroe SM, Simons AD . Diathesis-stress theories in the context of life stress research: implications for the depressive disorders Psychol Bull 1991; 110: 406\u2013425","journal-title":"Psychol Bull"},{"key":"BF4000697_CR183","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1017\/S0033291700041301","volume":"11","author":"R Finlay-Jones","year":"1981","unstructured":"Finlay-Jones R, Brown GW . Types of stressful life events and the onset of anxiety and depressive disorders Psychol Med 1981; 11: 803\u2013816","journal-title":"Psychol Med"},{"key":"BF4000697_CR184","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/00006842-199305000-00002","volume":"55","author":"RS Lazarus","year":"1993","unstructured":"Lazarus RS . Coping theory and research: past, present, and future Psychosom Med 1993; 55: 234\u2013247","journal-title":"Psychosom Med"},{"key":"BF4000697_CR185","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1037\/0021-843X.100.4.555","volume":"100","author":"C Hammen","year":"1991","unstructured":"Hammen C . Generation of stress in the course of unipolar depression J Abn Psychol 1991; 100: 555\u2013561","journal-title":"J Abn Psychol"},{"key":"BF4000697_CR186","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1080\/00223891.1990.9674096","volume":"55","author":"JC Overholser","year":"1990","unstructured":"Overholser JC . Emotional reliance and social loss: effects on depressive symptomatology J Pers Assess 1990; 55: 618\u2013629","journal-title":"J Pers Assess"},{"key":"BF4000697_CR187","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0165-0327(96)00045-6","volume":"40","author":"AV Ravindran","year":"1996","unstructured":"Ravindran AV, Griffiths J, Merali Z, Anisman H . Primary dysthymia: a study of several psychosocial, endocrine and immunecorrelates J Affect Disord 1996; 40: 73\u201384","journal-title":"J Affect Disord"},{"key":"BF4000697_CR188","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/0278-5846(95)00108-8","volume":"19","author":"A Ravindran","year":"1995","unstructured":"Ravindran A, Griffiths J, Waddell C, Anisman H . Stressful life events and coping styles in dysthymia and major depressivedisorder: variations associated with alleviation of symptomsfollowing pharmacotherapy Prog Neuro-Psychopharmacol BiolPsychiatry 1995; 19: 637\u2013653","journal-title":"Prog Neuro-Psychopharmacol BiolPsychiatry"},{"key":"BF4000697_CR189","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1097\/00005053-198811000-00003","volume":"176","author":"JP McCullough","year":"1988","unstructured":"McCullough JP, Kasnetz MD, Braith JA, Carr KF, Cones JH, Fielo J et al. A longitudinal study of an untreated sample of predominantly late onset characterological dysthymia J Nerv Ment Dis 1988; 176: 658\u2013667","journal-title":"J Nerv Ment Dis"},{"key":"BF4000697_CR190","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1017\/S0033291700052181","volume":"11","author":"S Benjaminsen","year":"1981","unstructured":"Benjaminsen S . Stressful life events preceding the onset of neurotic depression Psychol Med 1981; 11: 369\u2013378","journal-title":"Psychol Med"},{"key":"BF4000697_CR191","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0010-440X(85)90038-0","volume":"26","author":"SM Monroe","year":"1985","unstructured":"Monroe SM, Thase ME, Hersen M, Himmelhoch JM, Bellack AS . Life events and the endogenous-non-endogenous distinction in the treatment and posttreatment course of depression Comp Psychiatry 1985; 26: 175\u2013186","journal-title":"Comp Psychiatry"},{"key":"BF4000697_CR192","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1037\/0021-843X.99.3.284","volume":"99","author":"JR Dura","year":"1990","unstructured":"Dura JR, Stukenberg KW, Kiecolt-Glaser JK . Chronic stress and depressive disorder in older adults J Abn Psychol 1990; 99: 284\u2013290","journal-title":"J Abn Psychol"},{"key":"BF4000697_CR193","doi-asserted-by":"publisher","first-page":"632","DOI":"10.3928\/0048-5713-19931101-10","volume":"23","author":"RA Friedman","year":"1993","unstructured":"Friedman RA . Social impairment in dysthymia Psychiat Ann 1993; 23: 632\u2013637","journal-title":"Psychiat Ann"},{"key":"BF4000697_CR194","doi-asserted-by":"publisher","first-page":"60S","DOI":"10.1097\/00004714-199508001-00011","volume":"15","author":"V Walker","year":"1995","unstructured":"Walker V, Streiner DL, Novosel S, Rocchi A, Levine MAH, Dean DM . Health-related quality of life in patients with major depression who are treated with moclobemide J Clin Psychopharmacol 1995; 15: 60S\u201367S","journal-title":"J Clin Psychopharmacol"},{"key":"BF4000697_CR195","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1001\/jama.1989.03430070062031","volume":"262","author":"K Wells","year":"1989","unstructured":"Wells K, Stewart A, Hays R, Burnam M, Rogers W, Daniels M et al. The functioning and well-being of depressed patients: results from the Medical Outcome Study JAMA 1989; 262: 914\u2013919","journal-title":"JAMA"},{"key":"BF4000697_CR196","first-page":"78","volume-title":"Dysthymic Disorders","author":"GB Cassano","year":"1990","unstructured":"Cassano GB, Perugi G, Maremmani I, Akiskal HS . Social adjustment in dysthymia. In: Burton SW, Akiskal HS (eds) Dysthymic Disorders Gaskell: London 1990; pp78\u201385"},{"key":"BF4000697_CR197","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0165-0327(86)90029-7","volume":"10","author":"G De Lisio","year":"1986","unstructured":"De Lisio G, Maremmani I, Perugi G, Cassano GB, Deltito J, Akiskal HS . Impairment of work and leisure in depressed outpatients J Affect Disord 1986; 10: 79\u201384","journal-title":"J Affect Disord"},{"key":"BF4000697_CR198","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1600-0447.1994.tb05877.x","volume":"89","author":"HL Freeman","year":"1994","unstructured":"Freeman HL . Historical and nosological aspects of dysthymia Acta Psychiat Scand 1994; 89: 7\u201311","journal-title":"Acta Psychiat Scand"},{"key":"BF4000697_CR199","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0165-0327(95)00076-3","volume":"37","author":"JB Leader","year":"1996","unstructured":"Leader JB, Klein DN . Social adjustment in dysthymia, double depression and episodic major depression J Affect Disord 1996; 37: 91\u2013101","journal-title":"J Affect Disord"},{"key":"BF4000697_CR200","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0165-0327(96)00067-5","volume":"41","author":"JC Markowitz","year":"1996","unstructured":"Markowitz JC, Friedman RA, Miller N, Spielman LA, Moran ME, Kocsis JH . Interpersonal improvement in chronically depressed patients treated with desipramine J Affect Disord 1996; 41: 59\u201362","journal-title":"J Affect Disord"},{"key":"BF4000697_CR201","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0165-0327(91)90033-O","volume":"23","author":"V Agosti","year":"1991","unstructured":"Agosti V, Stewart JW, Quitkin FM . Life satisfaction and psychosocial functioniong in chronic depression: effect of acute treatment with antidepressants J Affect Disord 1991; 23: 35\u201341","journal-title":"J Affect Disord"},{"key":"BF4000697_CR202","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1176\/ajp.154.3.390","volume":"154","author":"JH Kocsis","year":"1997","unstructured":"Kocsis JH, Zisook S, Davidson J, Shelton R, Yonkers K, Hellerstein DJ et al. Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes Am J Psychiatry 1997; 154: 390\u2013395","journal-title":"Am J Psychiatry"},{"key":"BF4000697_CR203","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0165-0327(96)01403-6","volume":"42","author":"DN Klein","year":"1997","unstructured":"Klein DN, Lewinsohn PM, Seeley JR . Psychosocial characteristics of adolescents with a past history of dysthymic disorder: comparison with adolescents with past histories of major depression and non affective disorders, and never mentally ill controls J Affect Disord 1997; 42: 127\u2013135","journal-title":"J Affect Disord"},{"key":"BF4000697_CR204","doi-asserted-by":"publisher","first-page":"608","DOI":"10.4088\/JCP.v59n1108","volume":"59","author":"IW Miller","year":"1998","unstructured":"Miller IW, Keitner GI, Schatzberg AF, Klein DN, Thase ME, Rush AJ et al. The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline and imipramine J Clin Psychiatry 1998; 59: 608\u2013619","journal-title":"J Clin Psychiatry"},{"key":"BF4000697_CR205","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1192\/S0007125000293276","volume":"26","author":"J Fawcett","year":"1994","unstructured":"Fawcett J . Antidepressants: partial response in chronic depression Br J Psychiatry Suppl 1994; 26: 37\u201341","journal-title":"Br J Psychiatry Suppl"},{"key":"BF4000697_CR206","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1001\/archpsyc.1971.01750160052010","volume":"25","author":"ES Paykel","year":"1971","unstructured":"Paykel ES, Prusoff BA, Uhlenhuth EH . Scaling of life events Arch Gen Psychiatry 1971; 25: 340\u2013347","journal-title":"Arch Gen Psychiatry"},{"key":"BF4000697_CR207","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1017\/S0033291700033134","volume":"25","author":"R Ramana","year":"1995","unstructured":"Ramana R, Paykel ES, Cooper Z, Hayhurst H, Saxty M, Surtees PG . Remission and relapse in major depression: a two year prospective follow-up study Psychol Med 1995; 25: 1161\u20131170","journal-title":"Psychol Med"},{"key":"BF4000697_CR208","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0278-5846(94)00101-M","volume":"19","author":"M Maes","year":"1995","unstructured":"Maes M . Evidence for an immune response in major depression: a review and hypothesis Prog Neuropsychopharmacol Biol Psychiatry 1995; 19: 11\u201338","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BF4000697_CR209","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1176\/ajp.150.8.1189","volume":"150","author":"M Maes","year":"1993","unstructured":"Maes M, Bosmans E, Meltzer HY, Scharpe S, Suy E . Interleukin-1 \u03b2: a putative mediator of HPA axis hyperactivity in major depression? Am J Psychiatry 1993; 150: 1189\u20131193","journal-title":"Am J Psychiatry"},{"key":"BF4000697_CR210","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1600-0447.1991.tb03163.x","volume":"84","author":"M Maes","year":"1991","unstructured":"Maes M, Bosmans E, Suy E, Vandervorst C, de Jonckheere C, Minner B et al. Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1\u03b2 and soluble interleukin-2 receptor production Acta Psychiatr Scand 1991; 84: 379\u2013386","journal-title":"Acta Psychiatr Scand"},{"key":"BF4000697_CR211","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1017\/S0033291700032712","volume":"22","author":"M Maes","year":"1992","unstructured":"Maes M, Lambrechts J, Bosmans E, Jacobs J, Suy E, Vandervorst C et al. Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining Psychol Med 1992; 22: 45\u201353","journal-title":"Psychol Med"},{"key":"BF4000697_CR212","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0165-0327(95)00028-L","volume":"34","author":"M Maes","year":"1995","unstructured":"Maes M, Meltzer HY, Bosmans E, Bergmans R, Vandoolaeghe E, Ranjan R et al. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression J Affect Disord 1995; 34: 301\u2013309","journal-title":"J Affect Disord"},{"key":"BF4000697_CR213","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0278-5846(97)00179-6","volume":"22","author":"N Mullar","year":"1998","unstructured":"Mullar N, Ackenheil M . Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders Prog Neuropsychopharm Biol Psychiatry 1998; 22: 1\u201333","journal-title":"Prog Neuropsychopharm Biol Psychiatry"},{"key":"BF4000697_CR214","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1600-0447.1993.tb03412.x","volume":"88","author":"L Nassberger","year":"1993","unstructured":"Nassberger L, Traskman-Bendz L . Increased soluble interleukin-2 receptor concentrations in suicide attempters Acta Psychiatr Scand 1993; 88: 48\u201352","journal-title":"Acta Psychiatr Scand"},{"key":"BF4000697_CR215","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/0306-9877(91)90272-Z","volume":"35","author":"RS Smith","year":"1991","unstructured":"Smith RS . The macrophage theory of depression Med Hypoth 1991; 35: 298\u2013306","journal-title":"Med Hypoth"},{"key":"BF4000697_CR216","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0165-0327(94)90135-X","volume":"30","author":"C Song","year":"1994","unstructured":"Song C, Dinan T, Leonard BE . Changes in immunoglobulin, complement and acute phase protein levels in depressed patients and normal controls J Affect Disord 1994; 30: 283\u2013288","journal-title":"J Affect Disord"},{"key":"BF4000697_CR217","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/j.1749-6632.1995.tb32372.x","volume":"762","author":"A Sluzewska","year":"1995","unstructured":"Sluzewska A, Rybakowski JK, Laciak M, Mackiewicz A, Sobieska M, Wiktorowicz K . Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine Ann NY Acad Sci 1995; 762: 474\u2013476","journal-title":"Ann NY Acad Sci"},{"key":"BF4000697_CR218","unstructured":"Anisman H, Ravindran AV, Griffiths J, Merali H . Interleukin-1 variations associated with dysthymia prior to and following antidepressant medication Biol Psychiatry (in press)"},{"key":"BF4000697_CR219","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/00006842-199511000-00008","volume":"57","author":"A Ravindran","year":"1995","unstructured":"Ravindran A, Griffiths J, Merali Z, Anisman H . Lymphocyte subsets in major depression and dysthymia: modification by antidepressant treatment Psychosomatic Med 1995; 57: 555\u2013563","journal-title":"Psychosomatic Med"},{"key":"BF4000697_CR220","first-page":"1350","volume":"22","author":"J Griffiths","year":"1996","unstructured":"Griffiths J, Ravindran AV, Merali Z, Anisman H . Immune and behavioral correlates of typical and atypical depression Soc Neurosci Abst 1996; 22: 1350","journal-title":"Soc Neurosci Abst"},{"key":"BF4000697_CR221","first-page":"337","volume":"148","author":"MA Demitrack","year":"1991","unstructured":"Demitrack MA, Dale JK, Straus SE, Laue L, Listwak SJ, Kruesi MJP et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome J Clin Endocrinol Metab 1991; 148: 337\u2013344","journal-title":"J Clin Endocrinol Metab"},{"key":"BF4000697_CR222","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1111\/j.1749-6632.1995.tb44723.x","volume":"771","author":"PW Gold","year":"1995","unstructured":"Gold PW, Licinio J, Wong ML, Chrousos GP . Corticotropin releasing hormone in pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs Ann NY Acad Sci 1995; 771: 716\u2013729","journal-title":"Ann NY Acad Sci"},{"key":"BF4000697_CR223","first-page":"719","volume-title":"Psychopharmacology: The Fourth Generation of Progress","author":"AJ Dunn","year":"1995","unstructured":"Dunn AJ . Interactions between the nervous system and the immune system: implications for psychopharmacology. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: The Fourth Generation of Progress Raven Press: New York 1995; pp719\u2013731"},{"key":"BF4000697_CR224","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1749-6632.1993.tb49926.x","volume":"697","author":"C Rivier","year":"1993","unstructured":"Rivier C . Effect of peripheral and central cytokines on the hypothalamic-pituitary-adrenal axis of the rat Ann NY Acad Sci 1993; 697: 97\u2013105","journal-title":"Ann NY Acad Sci"},{"key":"BF4000697_CR225","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-0-585-37970-8_2","volume":"461","author":"M Maes","year":"1999","unstructured":"Maes M . Major depression and activation of the inflammatory response system Adv Exp Med Biol 1999; 461: 25\u201346","journal-title":"Adv Exp Med Biol"},{"key":"BF4000697_CR226","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000026321","volume":"5","author":"L Capuron","year":"1998","unstructured":"Capuron L, Ravaud A, Radat F, Dantzer R, Goodall G . Affects of interleukin-2 and alpha-interferon cytokine immunotherapy on the mood and cognitive performance of cancer patients Neuroimmunomodulation 1998; 5: 9","journal-title":"Neuroimmunomodulation"},{"key":"BF4000697_CR227","first-page":"1266","volume":"29A","author":"A Caraceni","year":"1992","unstructured":"Caraceni A, Martini C, Belli F, Mascheroni L, Rivoltini L, Arienti F et al. Neuropsychological and neurophysiological assessment of the central effects of interleukin-2 administration Eur J Cancer 1992; 29A: 1266\u20131269","journal-title":"Eur J Cancer"},{"key":"BF4000697_CR228","doi-asserted-by":"publisher","first-page":"293","DOI":"10.7326\/0003-4819-107-2-293","volume":"107","author":"KD Denicoff","year":"1987","unstructured":"Denicoff KD, Rubinow DR, Papa MZ, Simpson L, Seipp LA, Lotze MT et al. The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells Ann Int Med 1987; 107: 293\u2013300","journal-title":"Ann Int Med"},{"key":"BF4000697_CR229","doi-asserted-by":"publisher","first-page":"56","DOI":"10.2165\/00023210-199503010-00006","volume":"3","author":"CA Meyers","year":"1995","unstructured":"Meyers CA, Valentine AD . Neurological and psychiatric adverse effects of immunological therapy CNS Drugs 1995; 3: 56\u201368","journal-title":"CNS Drugs"},{"key":"BF4000697_CR230","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/978-0-585-37970-8_5","volume":"461","author":"CA Meyers","year":"1999","unstructured":"Meyers CA . Mood and cognitive disorders in cancer patients receiving cytokine therapy Adv Exp Med Biol 1999; 461: 75\u201381","journal-title":"Adv Exp Med Biol"},{"key":"BF4000697_CR231","first-page":"1155","volume-title":"Psychopharma\u00edcology: The Fourth Generation of Progress","author":"RM Post","year":"1995","unstructured":"Post RM, Weiss SRB . The neurobiology of treatment-resistant mood disorders. In: Bloom FE, Kupfer DJ (eds) Psychopharma\u00edcology: The Fourth Generation of Progress Raven Press: New York 1995; pp1155\u20131170"},{"key":"BF4000697_CR232","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0165-0327(84)90061-2","volume":"7","author":"H Perris","year":"1984","unstructured":"Perris H . Life events and depression. Part 2. Results in diagnostic subgroups, and in relation to the recurrence of depression J Affect Disord 1984; 7: 25\u201336","journal-title":"J Affect Disord"},{"key":"BF4000697_CR233","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2165\/00023210-199504040-00004","volume":"4","author":"ME Thase","year":"1995","unstructured":"Thase ME, Sullivan LR . Relapse and recurrence of depression: a practical approach for prevention CNS Drugs 1995; 4: 261\u2013277","journal-title":"CNS Drugs"},{"key":"BF4000697_CR234","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1176\/ajp.149.8.999","volume":"149","author":"RM Post","year":"1992","unstructured":"Post RM . Transduction of psychosocial stress into the neurobiology of recurrent affective disorder Am J Psychiatry 1992; 149: 999\u20131010","journal-title":"Am J Psychiatry"},{"key":"BF4000697_CR235","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/978-0-585-37970-8_12","volume":"461","author":"H Anisman","year":"1999","unstructured":"Anisman H, Merali Z . Anhedonic and anxiogenic effects of cytokine exposure Adv Exp Med Biol 1999; 461: 199\u2013233","journal-title":"Adv Exp Med Biol"},{"key":"BF4000697_CR236","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0306-4530(87)90040-0","volume":"12","author":"ER De Kloet","year":"1987","unstructured":"De Kloet ER, Reul JMH . Feedback action and tonic influence of corticosteroids on brain function: a concept arising from heterogeneity of brain receptor systems Psychoneuroendocrinology 1987; 12: 83\u2013105","journal-title":"Psychoneuroendocrinology"},{"key":"BF4000697_CR237","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1192\/bjp.164.3.365","volume":"164","author":"TG Dinan","year":"1994","unstructured":"Dinan TG . Glucocorticoids and the genesis of depressive illness: a psychobiological model Br J Psychiatry 1994; 164: 365\u2013371","journal-title":"Br J Psychiatry"},{"key":"BF4000697_CR238","doi-asserted-by":"publisher","first-page":"4758","DOI":"10.1523\/JNEUROSCI.18-12-04758.1998","volume":"18","author":"Z Merali","year":"1998","unstructured":"Merali Z, McIntosh J, Kent P, Michaud D, Anisman H . Aversive as well as appetitive events evoke the release of corticotropin releasing hormone and bombesin-like peptides at the central nucleus of the amygdala J Neurosci 1998; 18: 4758\u20134766","journal-title":"J Neurosci"},{"key":"BF4000697_CR239","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0165-0173(91)90007-U","volume":"16","author":"PW Kalivas","year":"1991","unstructured":"Kalivas PW, Stewart J . Dopamine transmission in the initiation and expression of drug-and stress-induced sensitization of motor activity Brain Res Rev 1991; 16: 223\u2013244","journal-title":"Brain Res Rev"},{"key":"BF4000697_CR240","first-page":"336","volume":"1","author":"CB Nemeroff","year":"1996","unstructured":"Nemeroff CB . The corticotropin-releasing factor (CRF) hypothsesis of depression: new findings and new directions Mol Psychiatry 1996; 1: 336\u2013342","journal-title":"Mol Psychiatry"},{"key":"BF4000697_CR241","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S0006-3223(96)00432-5","volume":"41","author":"RD Levitan","year":"1997","unstructured":"Levitan RD, Kaplan AS, Brown GM, Joffe RT, Levitt AJ, Vaccarino FJ et al. Low plasma cortisol in bulimia nervosa patients with reversed neurovegetative symptoms of depression Biol Psychiatry 1997; 41: 366\u2013368","journal-title":"Biol Psychiatry"},{"key":"BF4000697_CR242","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0006-3223(97)00539-8","volume":"44","author":"R Catalan","year":"1998","unstructured":"Catalan R, Gallart JM, Castellanos JM, Galard R . Plasma corticotropin-releasing factor in depressive disorders Biol Psychiatry 1998; 44: 15\u201320","journal-title":"Biol Psychiatry"},{"key":"BF4000697_CR243","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1210\/endo.132.2.8425502","volume":"132","author":"V Bartanusz","year":"1993","unstructured":"Bartanusz V, Jezova D, Bertini LT, Tilders FJ, Aubry JM, Kiss JZ . Stress-induced increase in vasopressin and corticotropin-releasing factor expression in hypophysiotrophic paraventricular neurons Endocrinology 1993; 132: 895\u2013902","journal-title":"Endocrinology"},{"key":"BF4000697_CR244","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/j.1365-2826.1996.tb00707.x","volume":"8","author":"ED Schmidt","year":"1996","unstructured":"Schmidt ED, Binnbekade R, Janszen AWJW, Tilders FJH . Short stressor induced long-lasting increases of vasopressin stores in hypothalamic corticotropin-releasing hormone (CRH) neurons in adult rats J Neuroendocrinol 1996; 8: 703\u2013712","journal-title":"J Neuroendocrinol"},{"key":"BF4000697_CR245","doi-asserted-by":"publisher","first-page":"7417","DOI":"10.1523\/JNEUROSCI.15-11-07417.1995","volume":"15","author":"E Schmidt","year":"1995","unstructured":"Schmidt E, Janszen AWJW, Wouterlood FG, Tilders FJH . Interleukin-1 induced long-lasting changes in hypothalamic corticotropin-releasing hormone (CRH) neurons and hyperresponsiveness of the hypothalamic-pituitary-adrenal axis J Neurosci 1995; 15: 7417\u20137426","journal-title":"J Neurosci"},{"key":"BF4000697_CR246","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1749-6632.1993.tb49921.x","volume":"697","author":"FJH Tilders","year":"1993","unstructured":"Tilders FJH, Schmidt ED, De Goeij DCE . Phenotypic plasticity of CRF neurons during stress Ann NY Acad Sci 1993; 697: 39\u201352","journal-title":"Ann NY Acad Sci"},{"key":"BF4000697_CR247","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1749-6632.1998.tb09550.x","volume":"840","author":"FJH Tilders","year":"1998","unstructured":"Tilders FJH, Schmidt ED . Interleukin-1-induced plasticity of hypothalamic CRH neurons and long-term stress hyperresponsiveness Ann NY Acad Sci 1998; 840: 65\u201373","journal-title":"Ann NY Acad Sci"},{"key":"BF4000697_CR248","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1176\/ajp.141.5.619","volume":"141","author":"PW Gold","year":"1984","unstructured":"Gold PW, Chrousos GP, Kellner C, Post RM, Roy A, Augerinas P et al. Psychiatric implications of basic and clinical studies with corticotropin-releasing factor Am J Psychiatry 1984; 141: 619\u2013627","journal-title":"Am J Psychiatry"},{"key":"BF4000697_CR249","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0924-977X(92)90019-5","volume":"2","author":"CM Banki","year":"1992","unstructured":"Banki CM, Karmacsi L, Bissette G, Nemeroff CB . CSF corticotropin-releasing hormone and somatostatin in major depression: response to antidepressant treatment and relapse Eur Neuropsychopharmacol 1992; 2: 107\u2013113","journal-title":"Eur Neuropsychopharmacol"},{"key":"BF4000697_CR250","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/0167-5699(94)90205-4","volume":"15","author":"JE Blalock","year":"1994","unstructured":"Blalock JE . The syntax of immune-neuroendocrine communication Immunol Today 1994; 15: 504\u2013511","journal-title":"Immunol Today"},{"key":"BF4000697_CR251","first-page":"26","volume":"3","author":"AJ Dunn","year":"1990","unstructured":"Dunn AJ . Interleukin-1 as a stimulator of hormone secretion Prog NeuroEndocrinImmunol 1990; 3: 26\u201334","journal-title":"Prog NeuroEndocrinImmunol"},{"key":"BF4000697_CR252","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S0166-2236(96)10069-2","volume":"20","author":"JP Herman","year":"1997","unstructured":"Herman JP, Cullinan WE . Neurocircuitry of stress: central control of hypothalamo-pituitary-adrenocortical axis Trends Neurosci 1997; 20: 78\u201384","journal-title":"Trends Neurosci"},{"key":"BF4000697_CR253","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/B978-0-12-043780-1.50033-6","volume-title":"Psychoneuroimmunology","author":"LS Crnic","year":"1991","unstructured":"Crnic LS . Behavioral consequences of viral infection. In: Ader R, Felten DL, Cohen N (eds) Psychoneuroimmunology Academic Press: San Diego 1991; 749\u2013770"},{"key":"BF4000697_CR254","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s002130050630","volume":"137","author":"S Lacosta","year":"1998","unstructured":"Lacosta S, Merali Z, Anisman H . Influence of interleukin-1 on exploratory behaviors, plasma ACTH and cortisol, and central biogenic amines in mice Psychopharmacology 1998; 137: 351\u2013361","journal-title":"Psychopharmacology"},{"key":"BF4000697_CR255","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1523\/JNEUROSCI.15-04-02920.1995","volume":"15","author":"ACE Linthorst","year":"1995","unstructured":"Linthorst ACE, Flachskamm C, Muller-Preuss P, Holsboer F, Reul JMHM . Effect of bacterial endotoxin and interleukin-1\u03b2 on hippocampal serotonergic neurotransmission, behavioral activity, and free corticosterone levels: an in vivo microdialysis study J Neurosci 1995; 15: 2920\u20132934","journal-title":"J Neurosci"},{"key":"BF4000697_CR256","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S0306-4522(98)00271-1","volume":"88","author":"C Song","year":"1998","unstructured":"Song C, Merali Z, Anisman H . Systemically administered IL-1, IL-2 and IL-6 and mild stress influence in vivo monoamine variations in the nucleus accumbens Neuroscience 1998; 88: 823\u2013836","journal-title":"Neuroscience"},{"key":"BF4000697_CR257","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/0165-6147(92)90012-U","volume":"13","author":"S Kent","year":"1992","unstructured":"Kent S, Bluthe RM, Kelley KW, Dantzer R . Sickness behavior as a new target for drug development Trends Pharmacol Sci 1992; 13: 24\u201328","journal-title":"Trends Pharmacol Sci"},{"key":"BF4000697_CR258","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0736-5748(98)00025-2","volume":"16","author":"H Anisman","year":"1998","unstructured":"Anisman H, Zaharia MD, Meaney MJ, Merali Z . Proactive hormonal, neurochemical and behavioral effects of early life stimulation; genetic differences Int J Dev Neurosci 1998; 16: 149\u2013164","journal-title":"Int J Dev Neurosci"},{"key":"BF4000697_CR259","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000111395","volume":"18","author":"MJ Meaney","year":"1996","unstructured":"Meaney MJ, Diorio J, Francis D, Widdowson J, LaPlante P, Caldji C et al. Early environmental regulation of forebrain glucocorticoid receptor gene expression: implications for adrenocortical responses to stress Dev Neuroscience 1996; 18: 49\u201372","journal-title":"Dev Neuroscience"},{"key":"BF4000697_CR260","volume-title":"Dysthymia and the Spectrum of Chronic Depressions","author":"HS Akiskal","year":"1997","unstructured":"Akiskal HS, Cassano GB . Dysthymia and the Spectrum of Chronic Depressions Guilford Press: New York 1997"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/4000697.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/4000697","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/4000697.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T04:20:22Z","timestamp":1648786822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/4000697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5,1]]},"references-count":260,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,5,1]]}},"alternative-id":["BF4000697"],"URL":"https:\/\/doi.org\/10.1038\/sj.mp.4000697","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,5,1]]},"assertion":[{"value":"10 June 1999","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 1999","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 1999","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2000","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}